PROCEPT BioRobotics Corporation
PRCT
Rank in Stocks
#7627
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic... PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Share Price
$22.37
Last synced: 2026-11-09
Market Cap
$1.28B
Change (1 day)
8.49%
Change (1 year)
-28.62%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade PROCEPT BioRobotics Corporation (PRCT)
Category
Healthcare
Operating Margin for PROCEPT BioRobotics Corporation (PRCT)
Operating Margin as of November 2026 TTM: -33.86%
According to PROCEPT BioRobotics Corporation's latest financial reports, its current operating margin (TTM) is -33.86%. At the end of 2025 the company had an operating margin of -33.71%.
Operating Margin history for PROCEPT BioRobotics Corporation from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -33.86% | 0.44% |
| 2025 | -33.71% | -21.68% |
| 2024 | -43.04% | -46.31% |
| 2023 | -80.16% | -25.51% |
| 2022 | -107.61% | -31.51% |
| 2021 | -157.12% | -74.64% |
| 2020 | -619.44% | -12.25% |
| 2019 | -705.95% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.45% |
US
|
|
| 18.08% | -100.53% |
IE
|
|
| 21.25% | -100.63% |
US
|
|
| 21.05% | -100.62% |
US
|
|
| 28.09% | -100.83% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PROCEPT BioRobotics Corporation's operating margin
What is PROCEPT BioRobotics Corporation's operating margin?
PROCEPT BioRobotics Corporation's operating margin is -33.86%, as of Nov 2026.
What was PROCEPT BioRobotics Corporation's operating margin in 2025?
In 2025, PROCEPT BioRobotics Corporation's operating margin was -33.71%, compared with -43.04% in 2024.
How has PROCEPT BioRobotics Corporation's operating margin changed since 2020?
From 2020 to 2025, PROCEPT BioRobotics Corporation's operating margin was highest in 2025 (-33.71%) and lowest in 2020 (-619.44%).
How does PROCEPT BioRobotics Corporation's operating margin compare with similar companies?
PROCEPT BioRobotics Corporation's operating margin (-33.86%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.